Companies are using ‘clinical-grade’ AI as a marketing term to imply medical rigor without regulatory oversight. This linguistic sleight of hand creates consumer confusion while avoiding FDA scrutiny.
Strong Quarterly Results Drive Upward Revision in Annual Forecast Medical technology leader Boston Scientific has raised its full-year profit guidance…
Healthcare’s AI Revolution Accelerates with Major Funding While much attention in artificial intelligence has focused on general-purpose models like ChatGPT,…
